Principal's Profile

Name : SUBHAJIT GHANTY

Birth Date: 07th Jan-1980.

Languages Known: English, Hindi and Bengali.

Communication : subhajitmpharm@gmail.com

Mr. Ghanty has M. Pharm (Pharmaceutical Analyst & QA) from Roland Institute of Pharmaceutical Sciences under BPUT university. He is persuing phd in Pharmaceutical Technology from MAKAUT university. He had more than 15 year experience in Different field of pharmaceutical industry and teaching experience. He guided 8 post graduate students. His area of interest in analytical method development for Related substance and validation.

• U V & Visible Spectrophotometer (ELICO SL 159 Single beam).& UV-1700 ; IES(Pharma Spec) SHIMADZU
• HPLC (SHIMADZU with class-10vp Software with Binary Gradient with UV- Visible Detector (SPD-10A), PUMP (LC-10AT) and (LC-10ATvp) with Auto sampler.
• HPLC (Waters Alliance 2695 separation module system, waters 2996 photo Diode Array Detector, water Empower Chromatography Software).
• HPLC (Ultimate 3000 HPLC pump, Ultimate 3000 Auto sampler, Ultimate 3000 Column compartment, Ultimate 3000 Diode Array detector, RF Detector, Dionex Chrome eon Series chromatography software)
• Dissolution Test Apparatus-Eight stage, DISSO 2000 with Auto sampler(LAB INDIA)
• RRLC (AGILENT TECHNOLOGIES 1200 Series)

Phd in Pharmaceutical Technology Pursuing phd in Pharmaceutical Technology Under MKUT, University Kolkata.
Master in Pharmacy (2005-2007) 8.48 out of 10 CGPA scale with Specialization in Pharmaceutical analysis & Quality Assurance from Roland institute of Pharmaceutical Sciences, Berhampur, Biju Patnaik University of Technology, Rourkela, Orissa.
Bachelor of Pharmacy (2005) 7.88 out of 10 DGPA scale from Gupta college of Technological Sciences, Asansol, West Bengal University of Technology, Kolkata, West Bengal.

1. Siladitya Behera, Subhajit Ghanty, Fahad Ahmad, Saayak Santra, Sritoma Banerjee. UV-Visible Spectrophotometric Method Development and Validation of Assay of Paracetamol Tablet Formulation International. J. of Chemical and Analytical Science . 2012 ; 3(12) : 1656-1661 (ISSN: 0976-1206)

2. Ghanty S*, Sadhukhan N. Mondal A. Development and Validation of a UVSpectrophotometric Method for Quantification of Atorvastatin in Tablets J. PharmaSciTech. 2012; 2(1) : 34-40 (ISSN: 2231 3788)

3. Subhajit Ghanty *, Rudranil Das, Sabyasachi Maiti, Kalyan Kumar Sen . RP-HPLC Method for Estimation of Valsartan in Solid Oral Dosage Forms, J. PharmaSciTech. 2014 ; 3 (2) : 88-91 (ISSN : 2321 4376)

1. AICTE sponsored National Conference on Biopolymers, Bioactive agents & Delivery strategies, April 7th -8 th 2012 organized by-Trinity trust, Gupta College of technological sciences, Asansol.

2. Seminar and Workshop on Industry-Entrepreneurship Development Programmed, 8th 10th September, 2012 organized by-Trinity trust, Gupta College of Technological sciences, Asansol

3. Trinity Trust, Gupta College of Technological Sciences, Asansol in collaboration with APTI organized National Seminar on Strategies to Combat Diseases Threatening the Nations Health, September 5th 2013.

4. A Seminar on High Throughput & Molecular Targeted Screening in Anticancer drug Discovery held on 11th November, 2013 at AJC BOSE HALL, Gupta college of Technological Sciences, Ashram More, G.T. Road, Asansol-713301, West Bengal .

5. AICTE sponsored National Conference on Complex Diseases, Novel Therapeutics & Delivery Challenges, 23rd -24th January, 2014 organized by-Trinity trust, Gupta college of Technological Sciences, Ashram More, G.T. Road, Asansol-713301, West Bengal

Research Carried out (M.Pharm) project under my supervision

1) Study of the Quality by design (QBD) approach in pharmaceutical product development of generic immediate release tablets to implement the regulatory requirement of (USFDA)
2) Bioequivalance study of Azathioprine tablets 2 x50 mg dose administration to healthy male volunteer using liquid chromatography tandem mass spectroo (LCMS/ MS)
3) European regulations realated to stability and bioequivalance study of pharmaceutical product for human use.
4) Study of essential parameters of quality management system and risk assessment in pharmaceutical industry.
5) Formulation development and evaluation of atorvastatin calcium
beta-cyclodextrin inclusion complex to form tablets.
6) UV-Spectro photometric method development for analysis of Metaprolol succinate in tablets dosage form.
7) Bioequivalent study comparison between Indian and other regulatory market.
8) Method development and validation for analysis of Valsartan present in tablet dosage form.

• Guide about Fifteen student in B. Pharm project

1. M.Pharm C-GMP, Quality Assurance, regulatory Affairs classes
2. Taking Theory and practical classes of pharmaceutical analysis, Pharmacognosy, Pharmaceutical Jurisprudence & Ethics .
3. Analytical method development for new and existing formulated products Tablets, Capsules, Syrup, Suspensions, Formulations.
4. HPLC method validation for new and developed methods for analysis of Related substances, Assay and Dissolution for USFDA.
5. Reconstitution Stability Study for Injections.
6. Stability Study of New formulated product as per ICH Guidelines.
7. Calibration of Instruments like HPLC, Dissolution Apparatus , UV Spectrophotometer , KF Apparatus.
8. Documentation works like preparation of development files preparation of excel calculation sheet, protocol, reports for analytical method validations protocol & report preparation, calibration record.
9. Preparation of SOPs for different instrument